Prescription Patterns of Antidementia and Psychotropic Drugs in People Living With Dementia: Findings From the Clinical Pathway Study of Alzheimer's Disease in China

2021 ◽  
Author(s):  
Yingyang Zhang ◽  
Hao Luo ◽  
Gloria H.Y. Wong ◽  
Mei Zhao ◽  
Xiaozhen Lv ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Psychotropic Drugs ◽  
Clinical Pathway ◽  
Prescription Patterns

Delayed help seeking behavior in dementia care: preliminary findings from the Clinical Pathway for Alzheimer's Disease in China (CPAD) study

2015 ◽  
Vol 28 (2) ◽  
pp. 211-219 ◽  
Author(s):  
Mei Zhao ◽  
Xiaozhen Lv ◽  
Maimaitirexiati Tuerxun ◽  
Jincai He ◽  
Benyan Luo ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Family History ◽  
Clinical Pathway ◽  
Help Seeking ◽  
Univariate Analysis ◽  
Positive Family History ◽  
Dementia Care ◽  
Factors Associated ◽  
People With Dementia

ABSTRACTBackground:The prevalence and factors associated with delays in help seeking for people with dementia in China are unknown.Methods:Within 1,010 consecutively registered participants in the Clinical Pathway for Alzheimer's Disease in China (CPAD) study (NCT01779310), 576 persons with dementia (PWDs) and their informants reported the estimated time from symptom onset to first medical visit seeking diagnosis. Univariate analysis of general linear model was used to examine the potential factors associated with the delayed diagnosis seeking.Results:The median duration from the first noticeable symptom to the first visit seeking diagnosis or treatment was 1.77 years. Individuals with a positive family history of dementia had longer duration (p= 0.05). Compared with other types of dementia, people with vascular dementia (VaD) were referred for diagnosis earliest, and the sequence for such delays was: VaD < Alzheimer's disease (AD) < frontotemporal dementia (FTD) (p< 0.001). Subtypes of dementia (p< 0.001), family history (p= 0.01), and education level (p= 0.03) were associated with the increased delay in help seeking.Conclusions:In China, seeking diagnosis for PWDs is delayed for approximately 2 years, even in well-established memory clinics. Clinical features, family history, and less education may impede help seeking in dementia care.

Psychotropic Drugs in Patients With Alzheimer's Disease: A Longitudinal Study by the Registry of Dementias of Girona (ReDeGi) in Catalonia, Spain

2014 ◽  
Vol 15 (7) ◽  
pp. 497-503 ◽  
Author(s):  
Laia Calvó-Perxas ◽  
Oriol Turró-Garriga ◽  
Maria Aguirregomozcorta ◽  
Josep Bisbe ◽  
Erélido Hernández ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Longitudinal Study ◽  
Psychotropic Drugs

P2-111: Effect of psychotropic drugs on development of diabetes mellitus in patients with Alzheimer's disease

2015 ◽  
Vol 11 (7S_Part_11) ◽  
pp. P526-P526
Author(s):  
Ki Jung Chang ◽  
Sang Joon Son ◽  
Dongsoo Kim ◽  
Kang Soo Lee ◽  
Hyung Woong Roh ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Psychotropic Drugs

Cerebral Pharmacodynamics of Physostigmine in Alzheimer's Disease Investigated Using Single-Photon Computerised Tomography

1991 ◽  
Vol 158 (3) ◽  
pp. 351-357 ◽  
Author(s):  
R. Hunter ◽  
D. J. Wyper ◽  
J. Patterson ◽  
M. T. Hansen ◽  
G. M. Goodwin
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Psychotropic Drugs ◽  
Brain Function ◽  
Single Photon ◽  
Computerised Tomography ◽  
Psychiatric Illnesses ◽  
Regional Brain ◽  
Hmpao Spect ◽  
Antidementia Drugs

The effects of physostigmine on patterns of rCBF in patients with pre-senile Alzheimer's disease were studied using 99mTc-labelled HMPAO SPECT. Regional CBF increased in the left cortex relative to right, with the most significant effect in left frontal and higher frontal regions. Measures of regional brain function, such as SPECT, are an important complement to psychological test batteries in understanding the effects in brain of putative antidementia drugs. SPECT brain imaging could extend our understanding of the action of psychotropic drugs in other major psychiatric illnesses.

scholarly journals Prescription Patterns of Medications for Alzheimer’s Disease in Japan from 2010 to 2015: A Descriptive Pharmacy Claims Database Study

2016 ◽  
Vol 6 (1) ◽  
pp. 25-37 ◽  
Author(s):  
Kimiko Kadohara ◽  
Izumi Sato ◽  
Yuko Doi ◽  
Masaru Arai ◽  
Yosuke Fujii ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Prescription Patterns ◽  
Claims Database ◽  
Database Study ◽  
Pharmacy Claims
Sign in / Sign up

Export Citation Format

Share Document